Cubist Systematic Strategies’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Cubist Systematic Strategies’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-251,483	Closed	-$14.1K	–	4269
2023 Q3	$14.1K	Sell	251,483 -9,000	-3%	-$1.08K	﹤0.01%	3123
2023 Q2	$38.4K	Sell	260,483 -9,200	-3%	-$952	﹤0.01%	3124
2023 Q1	$25.6K	Hold	269,683	–	–	﹤0.01%	3650
2022 Q4	$26.9K	Hold	269,683	–	–	﹤0.01%	3971
2022 Q3	$22K	Hold	269,683	–	–	﹤0.01%	4233
2022 Q2	$38K	Hold	269,683	–	–	﹤0.01%	4137
2022 Q1	$62K	Buy	+269,683	New	+$70K	﹤0.01%	3341

Cubist Systematic Strategies's BIOSW Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 251,483 shares — an estimated $14.1K sold.

Cubist Systematic Strategies first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $62K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Cubist Systematic Strategies reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 251,483 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $14.1K.
Cubist Systematic Strategies first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Cubist Systematic Strategies's BioPlus Acquisition Corp. Warrants position peaked at $62K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.